Compile Data Set for Download or QSAR
maximum 50k data
Found 51 with Last Name = 'zepp' and Initial = 'cm'
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235724(US10117875, Example 67 | US9359361, 67)
Affinity DataIC50:  25nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235724(US10117875, Example 67 | US9359361, 67)
Affinity DataIC50:  25nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235714(US10117875, Example 54 | US9359361, 54)
Affinity DataIC50:  62nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235714(US10117875, Example 54 | US9359361, 54)
Affinity DataIC50:  62nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232965(US9353115, 1)
Affinity DataIC50:  72nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235721(US10117875, Example 63 | US9359361, 63)
Affinity DataIC50:  112nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235721(US10117875, Example 63 | US9359361, 63)
Affinity DataIC50:  112nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235716(US10117875, Example 57 | US9359361, 57)
Affinity DataIC50:  113nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235716(US10117875, Example 57 | US9359361, 57)
Affinity DataIC50:  113nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235730(US10117875, Example 73 | US9359361, 73)
Affinity DataIC50:  124nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235730(US10117875, Example 73 | US9359361, 73)
Affinity DataIC50:  124nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235727(US10117875, Example 70 | US9359361, 70)
Affinity DataIC50:  137nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235727(US10117875, Example 70 | US9359361, 70)
Affinity DataIC50:  137nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232966(US9353115, 54)
Affinity DataIC50:  142nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235732(US10117875, Example 66 | US9359361, 66)
Affinity DataIC50:  181nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235732(US10117875, Example 66 | US9359361, 66)
Affinity DataIC50:  181nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235723(US10117875, Example 65 | US9359361, 65)
Affinity DataIC50:  198nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235723(US10117875, Example 65 | US9359361, 65)
Affinity DataIC50:  198nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232969(US9353115, 57)
Affinity DataIC50:  271nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235725(US10117875, Example 68 | US9359361, 68)
Affinity DataIC50:  273nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235725(US10117875, Example 68 | US9359361, 68)
Affinity DataIC50:  273nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235713(US10117875, Example 1 | US9359361, 1)
Affinity DataIC50:  285nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235713(US10117875, Example 1 | US9359361, 1)
Affinity DataIC50:  285nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235715(US10117875, Example 56 | US9359361, 56)
Affinity DataIC50:  317nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235715(US10117875, Example 56 | US9359361, 56)
Affinity DataIC50:  317nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235729(US10117875, Example 72 | US9359361, 72)
Affinity DataIC50:  487nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235729(US10117875, Example 72 | US9359361, 72)
Affinity DataIC50:  487nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232975(US9353115, 63)
Affinity DataIC50:  497nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232972(US9353115, 60)
Affinity DataIC50:  604nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235731(US10117875, Example 74 | US9359361, 74)
Affinity DataIC50:  901nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235731(US10117875, Example 74 | US9359361, 74)
Affinity DataIC50:  901nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235717(US10117875, Example 59 | US9359361, 59)
Affinity DataIC50:  991nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235717(US10117875, Example 59 | US9359361, 59)
Affinity DataIC50:  991nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235718(US10117875, Example 60 | US9359361, 60)
Affinity DataIC50:  2.18E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235718(US10117875, Example 60 | US9359361, 60)
Affinity DataIC50:  2.18E+3nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235726(US10117875, Example 69 | US9359361, 69)
Affinity DataIC50:  2.48E+3nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235726(US10117875, Example 69 | US9359361, 69)
Affinity DataIC50:  2.48E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235720(US10117875, Example 62 | US9359361, 62)
Affinity DataIC50:  2.49E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235720(US10117875, Example 62 | US9359361, 62)
Affinity DataIC50:  2.49E+3nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232973(US9353115, 61)
Affinity DataIC50:  2.74E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235722(US10117875, Example 64 | US9359361, 64)
Affinity DataIC50:  2.95E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235722(US10117875, Example 64 | US9359361, 64)
Affinity DataIC50:  2.95E+3nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232974(US9353115, 62)
Affinity DataIC50:  3.29E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235728(US10117875, Example 71 | US9359361, 71)
Affinity DataIC50:  3.82E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235728(US10117875, Example 71 | US9359361, 71)
Affinity DataIC50:  3.82E+3nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232967(US9353115, 55)
Affinity DataIC50:  5.20E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232971(US9353115, 59)
Affinity DataIC50:  7.53E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM232968(US9353115, 56)
Affinity DataIC50:  8.01E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235719(US10117875, Example 61 | US9359361, 61)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235719(US10117875, Example 61 | US9359361, 61)
Affinity DataIC50: >1.00E+4nMAssay Description:HEK-Blue-hTLR9 cells were obtained from InvivoGen Inc. and used to determine test compound antagonism of human TLR9 (hTLR9) driven responses. HEK-Blu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: